Mon panier

Apolipoprotein E

Apolipoprotein E Informations sur la molécule

Nom anglaisApolipoprotein ENombre de médicaments commercialisés0
Nombre de médicaments cliniques2Alias de la cibleAPOE,Apolipoprotein E,Alzheimer Disease 2 (APOE*E4-Associated, Late Onset),Apolipoprotein E3,LDLCQ5,Apo-E,LPG,AD2,Apolipoproteins E
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisApolipoprotein E
Alias de la cibleAPOE,Apolipoprotein E,Alzheimer Disease 2 (APOE*E4-Associated, Late Onset),Apolipoprotein E3,LDLCQ5,Apo-E,LPG,AD2,Apolipoproteins E
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2
Phase de R&D la plus avancéePhase 2 Clinical

Apolipoprotein E Liste de produits

  • Attribut

    Protein (13)

  • Bibliothèque de produits

    En ligne (12)En recherche (1)

  • Espèces

    Human (11)Mouse (1)Cynomolgus (1)

  • Étiquette

    His Tag (5)His Tag & Avi Tag (4)Tag Free (4)

  • Marqueur

    Unconjugated (9)Biotin-labeled (4)

Apolipoprotein EContexte de la molécule

APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles.

Apolipoprotein EAlias de la molécule

Apolipoprotein E,APOE,Apo-E

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
CN-105CN-105Phase 2 ClinicalAegiscn LlcCerebral Hemorrhage; Ischemic Stroke; Stroke
Details
TML-6TML-6Phase 2 ClinicalMerry Life Biomedical Co LtdAlzheimer Disease
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques